London Health Sciences Centre Research Institute

This study is testing if a new medication called AV-001 can protect the brain from damage that sometimes happens during dialysis treatments. It will involve 60 patients on long-term dialysis, who will receive either the drug or a placebo before three dialysis sessions in one week…